insulin degludec / liraglutide Pen Injector [Xultophy]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Xultophy® (IDegLira) is a fixed ratio combination of basal insulin degludec and glucagon-like peptide-1 (GLP-1) receptor agonist… (More)
Is this relevant?
Review
2015
Review
2015
Insulin degludec/liraglutide (Xultophy®), a fixed-ratio combination of an ultra-long-acting insulin analogue and a glucagon-like… (More)
  • table 1
  • figure 1
Is this relevant?